Key facts
- This page summarizes David P. Williams's Form 4 filing for CHEMED CORP (CHE).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 15 Nov 2023, 11:27.
David P. Williams - 13 Nov 2023 Form 4 Insider Report for CHEMED CORP (CHE)
- Reporting relationship
- executive vice president & CFO
- Issuer ticker
- CHE
- Reported as of
- 13 Nov 2023
- Net transaction value
- -$2,931,315
- SEC form
- 4
- Accepted by SEC
- 15 Nov 2023, 11:27:13 UTC
- Prior SEC filing
- 13 Nov 2023
- Source filing
- View source filing
- Reporting owner signature
- David P. Williams
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
David P. Williams filed Form 4 for CHEMED CORP (CHE) on 15 Nov 2023.
Change
- Previous filing in this sequence was filed on 13 Nov 2023.
- Current net transaction value: -$2,931,315.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CHE
transaction
capital stock
Sale
- Transaction value
- $2,236,224
- Shares
- -3,814
- Change %
- -35%
- Price
- $586.32
- Shares after
- 7,012
- Date
- 13 Nov 2023
- Ownership
- Direct
- Footnotes
- F1
CHE
transaction
capital stock
Sale
- Transaction value
- $695,091
- Shares
- -1,186
- Change %
- -17%
- Price
- $586.08
- Shares after
- 5,826
- Date
- 14 Nov 2023
- Ownership
- Direct
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $585.50 to $587.13. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.